SAN FRANCISCO—A retrospective study concluded that use of sugammadex (Bridion, Merck) is associated with significantly more postoperative pulmonary complications than neostigmine in patients recovering from bronchoscopy.
However, researchers added that while the findings were statistically significant, they were not clinically meaningful. What’s more, they hypothesized that the results may ultimately be a function of the different ways in which the drugs are used to reverse